Clinical proof-of-concept study with MSDC-0160, a prototype mTOT-modulating insulin sensitizer.
Saved in:
| Title: | Clinical proof-of-concept study with MSDC-0160, a prototype mTOT-modulating insulin sensitizer. |
|---|---|
| Authors: | Colca JR; Metabolic Solutions Development Company, Kalamazoo, Michigan, USA. jcolca@msdrx.com, VanderLugt JT, Adams WJ, Shashlo A, McDonald WG, Liang J, Zhou R, Orloff DG |
| Source: | Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2013 Apr; Vol. 93 (4), pp. 352-9. Date of Electronic Publication: 2013 Jan 18. |
| Publication Type: | Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-6535 (Electronic) Linking ISSN: 00099236 NLM ISO Abbreviation: Clin Pharmacol Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 23462886 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Clinical proof-of-concept study with MSDC-0160, a prototype mTOT-modulating insulin sensitizer. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Colca+JR%22">Colca JR</searchLink>; Metabolic Solutions Development Company, Kalamazoo, Michigan, USA. jcolca@msdrx.com<br /><searchLink fieldCode="AU" term="%22VanderLugt+JT%22">VanderLugt JT</searchLink><br /><searchLink fieldCode="AU" term="%22Adams+WJ%22">Adams WJ</searchLink><br /><searchLink fieldCode="AU" term="%22Shashlo+A%22">Shashlo A</searchLink><br /><searchLink fieldCode="AU" term="%22McDonald+WG%22">McDonald WG</searchLink><br /><searchLink fieldCode="AU" term="%22Liang+J%22">Liang J</searchLink><br /><searchLink fieldCode="AU" term="%22Zhou+R%22">Zhou R</searchLink><br /><searchLink fieldCode="AU" term="%22Orloff+DG%22">Orloff DG</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220372741%22">Clinical pharmacology and therapeutics</searchLink> [Clin Pharmacol Ther] 2013 Apr; Vol. 93 (4), pp. 352-9. <i>Date of Electronic Publication: </i>2013 Jan 18. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley%22">Wiley </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0372741 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1532-6535 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200099236%22">00099236 </searchLink><i>NLM ISO Abbreviation: </i>Clin Pharmacol Ther <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=23462886 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/clpt.2013.10 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 352 Titles: – TitleFull: Clinical proof-of-concept study with MSDC-0160, a prototype mTOT-modulating insulin sensitizer. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Colca JR – PersonEntity: Name: NameFull: VanderLugt JT – PersonEntity: Name: NameFull: Adams WJ – PersonEntity: Name: NameFull: Shashlo A – PersonEntity: Name: NameFull: McDonald WG – PersonEntity: Name: NameFull: Liang J – PersonEntity: Name: NameFull: Zhou R – PersonEntity: Name: NameFull: Orloff DG IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 04 Text: 2013 Apr Type: published Y: 2013 Identifiers: – Type: issn-electronic Value: 1532-6535 Numbering: – Type: volume Value: 93 – Type: issue Value: 4 Titles: – TitleFull: Clinical pharmacology and therapeutics Type: main |
| ResultId | 1 |
